Page 1 of Clinical Trials for ( Cephalon AND Inc ), 68 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 Mcg) Compared to Actiq® 400 Mcg, Cephalon, Inc.
Last Updated: July 30, 2010
Condition(s): Pain
2
Completed
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Last Updated: March 26, 2010
Condition(s): Narcolepsy; Sleep Apnea, Obstructive; Sleep Apnea Syndromes; Shift-Work Sleep Disorder
3
Completed
Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database
Last Updated: February 13, 2012
Condition(s): Epilepsy
4
Completed
Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg
Last Updated: March 31, 2008
Condition(s): Healthy
5
Completed
Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg
Last Updated: March 31, 2008
Condition(s): Healthy
6
Completed
Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)
Last Updated: July 6, 2010
Condition(s): Obstructive Sleep Apnea; Hypopnea
7
Completed
Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy
Last Updated: December 17, 2009
Condition(s): Narcolepsy
8
Completed
Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome
Last Updated: March 26, 2010
Condition(s): Obstructive Sleep Apnea; Sleep Hypopnea
9
Completed
Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD
Last Updated: May 14, 2010
Condition(s): Excessive Sleepiness; Shift Work Sleep Disorder
10
Enrolling by invitation
Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma
Last Updated: April 9, 2012
Condition(s): Eosinophilic Asthma
11
Enrolling by invitation
A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus Erythematosus
Last Updated: May 17, 2012
Condition(s): Systemic Lupus Erythematosus
12
Terminated
Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
Last Updated: November 16, 2010
Condition(s): Traumatic Brain Injury
13
Recruiting
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Last Updated: May 17, 2012
Condition(s): Depression
14
Recruiting
Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Last Updated: May 17, 2012
Condition(s): Depression
15
Recruiting
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Last Updated: May 17, 2012
Condition(s): Eosinophilic Asthma
16
Recruiting
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Last Updated: May 17, 2012
Condition(s): Eosinophilic Asthma
17
Recruiting
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Last Updated: May 17, 2012
Condition(s): Eosinophilic Asthma
18
Recruiting
Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)
Last Updated: May 17, 2012
Condition(s): Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma
19
Recruiting
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Last Updated: May 17, 2012
Condition(s): Depression
20
Completed
Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Last Updated: April 20, 2012
Condition(s): Pain

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Cephalon%2C+Inc

Page 1 of Clinical Trials for ( Cephalon AND Inc ), 68 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About